TB

The Becker Group

North America, Maryland, United States, Baltimore

Description

Transforming venues into a virtual wonderland.

Investor Profile

The Becker Group has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series F rounds (top funding stages).
  • Majority of deals are located in Israel.
  • Strong thematic focus on Biotechnology, Clinical Trials, Therapeutics.

Stage Focus

  • Series F (100%)

Country Focus

  • Israel (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does The Becker Group frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 1
Integra Holdings
Europe, Zurich, Switzerland, Wallisellen
Co-Investments: 1
Lundbeckfonden Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 1
Asahi Kasei
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Arix Bioscience
Europe, England, United Kingdom, London
Co-Investments: 1
SR One
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by The Becker Group?

Atox Bio

Ness Ziona, HaMerkaz, Israel

Atox Bio is a biotechnology company that specializes in infectious diseases, immunomodulators, and critical care.

BiotechnologyClinical TrialsTherapeutics
Series FDec 4, 2017
Amount Raised: $30,000,000

Find More Investors Like The Becker Group

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

The Becker Group | Pipeseed